Washington, DC 20006-5349
HELPLINE
Today, the Meso Foundation wrote a letter to the acting administrator of the EPA urging the agency to account for legacy asbestos when evaluating asbestos risk and the magnitude of the asbestos problem. This letter came as a response to the EPA’s decision to exclude legacy uses of asbestos in its problem formulation. This issue is separate from the recently publicized ‘significant new use rule.’ You can read more here.
EPA_Legacy_Comment_MesoFoundation
The Meso Foundation’s International Symposium on Malignant Mesothelioma is a unique conference that brings together the entire mesothelioma community. We invite patients, their families, caregivers,
The field of integrative medicine combines conventional therapies with complementary ones in a thoughtful way to optimize outcomes and/or quality of life. Services provided under
The Mesothelioma Applied Research Foundation is hiring! EXECUTIVE DIRECTOR Background The Mesothelioma Applied Research Foundation (Meso Foundation) is the nonprofit collaboration of patients and families,
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
